AMNM announces partnership agreement with GlobeMed Qatar

May 23, 2021

Doha: Alfardan Medical with Northwestern Medicine (AMNM), Qatar’s state-of-the-art medical and day surgery centre, signed a Memorandum of Understanding (MoU) with GlobeMed Qatar, the leading Healthcare Benefits Management company in Qatar.

As a Third Party Administrator (TPA), GlobeMed Qatar serves the portfolios of over eight insurance companies in Qatar, offering their members access to a wide network of healthcare providers.

Through this partnership, beneficiaries of any of the insurance companies serviced by GlobeMed Qatar can now benefit from AMNM’s advanced, patient-centric healthcare and latest medical equipment. Reimagining the future of healthcare in Qatar and beyond, AMNM provides high-quality, multidisciplinary medical care, and patient service.

AMNM’s world-class healthcare applies an American model of care, with a focus on advanced medicine practices, backed by a patient-centric approach, transparency, and teamwork that is evident in the services provided.

The sophisticated healthcare services are powered by a multinational collective of specialised medical staff and professionals from leading markets, including a large contingent from the US spanning across medical specialities, including ear, nose and throat, dentistry, dermatology, gastroenterology, internal medicine, ophthalmology, orthopedics, plastic surgery, fertility medicine and gynecology, physical medicine and rehabilitation, sleep medicine and executive health. Other AMNM medical specialities that will be introduced in the future include pediatrics, psychiatry and psychology.

Omar Hussain Alfardan, President and CEO of Alfardan Group (AFG), said, “Alfardan Group boasts over 65 years of legacy in delivering world-class premium experiences, with the guiding principles of quality, luxury and service excellence. Our partnership with GlobeMed will provide their members with access to the high-quality, advanced, and innovate healthcare services that are offered at AMNM.

“Having just recently opened in Lusail, we are steadily expanding the scope of our insurance coverage to ensure the high-calibre medical care available at AMNM is accessible to as many communities as possible”.

“We are delighted that our mission to deliver advanced, patient-centric care with service excellence, continues to be recognized by strategic stakeholders in the medical industry who are partnering with us to continue to drive the quality of healthcare forward,” he added.

The introduction of AMNM in Qatar marks Alfardan Group’s first venture in the healthcare sector. Located in the heart of Lusail City, AMNM is the result of a significant international collaboration between Alfardan Group and US-based Northwestern Medicine.

AMNM’s facilities have been designed around the patient’s experience, adhering to international benchmarks and standards of medical infrastructure, architectural design, and services. The medical and day surgery centre offers patients and their families an environment of privacy and comfort in a luxurious setting.

Dr. Samer Jaber, GlobeMed Regional Deputy General Manager said: “We are proud to partner with Alfardan Medical with Northwestern Medicine. By signing this MoU, we offer our clients’ insured members access to a prominent healthcare facility offering highly advanced and innovative healthcare services to serve all their healthcare needs.”

Dr. Jaber added, “GlobeMed Qatar is a member of GlobeMed Group the leading Healthcare Benefits Management Group in the Middle East with 30 years of experience and know-how in serving insurance companies and their insured members in 12 different markets in the Mena region and beyond. GlobeMed Qatar has established its leading position in the market by offering insured members exceptional customer experience and journey at every point of their service, giving them access to a wide network of healthcare providers. Through its patient-centric services and solutions, GlobeMed Qatar remains true to its promise of taking care of healthcare in Qatar.”

thepeninsulaqatar


healthcare

healthcare

Thought Leadership & Innovation Foundati...
June 9, 2021
Organon Launches as New Global Women&rsq...
June 8, 2021
Phase 3 Clinical Trial Subgroup Analysis...
June 7, 2021